- Home
- SPRY vs CET Comparison
SPRY vs CET Comparison
Compare SPRY & CET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRY
- CET
- Stock Information
- Founded
- SPRY 2015
- CET 1929
- Country
- SPRY United States
- CET United States
- Employees
- SPRY N/A
- CET N/A
- Industry
- SPRY Biotechnology: Pharmaceutical Preparations
- CET Finance/Investors Services
- Sector
- SPRY Health Care
- CET Finance
- Exchange
- SPRY Nasdaq
- CET Nasdaq
- Market Cap
- SPRY 1.8B
- CET 1.5B
- IPO Year
- SPRY N/A
- CET N/A
- Fundamental
- Price
- SPRY $11.63
- CET $51.93
- Analyst Decision
- SPRY Strong Buy
- CET
- Analyst Count
- SPRY 5
- CET 0
- Target Price
- SPRY $31.00
- CET N/A
- AVG Volume (30 Days)
- SPRY 2.8M
- CET 28.4K
- Earning Date
- SPRY 11-12-2025
- CET 01-01-0001
- Dividend Yield
- SPRY N/A
- CET 4.41%
- EPS Growth
- SPRY N/A
- CET N/A
- EPS
- SPRY N/A
- CET 7.40
- Revenue
- SPRY $112,339,000.00
- CET $27,062,484.00
- Revenue This Year
- SPRY N/A
- CET N/A
- Revenue Next Year
- SPRY $188.92
- CET N/A
- P/E Ratio
- SPRY N/A
- CET $6.99
- Revenue Growth
- SPRY 22367.80
- CET 15.78
- 52 Week Low
- SPRY $9.34
- CET $40.24
- 52 Week High
- SPRY $18.90
- CET $52.42
- Technical
- Relative Strength Index (RSI)
- SPRY 59.90
- CET 67.14
- Support Level
- SPRY $10.00
- CET $50.98
- Resistance Level
- SPRY $11.03
- CET $52.42
- Average True Range (ATR)
- SPRY 0.57
- CET 0.75
- MACD
- SPRY 0.35
- CET -0.02
- Stochastic Oscillator
- SPRY 96.13
- CET 73.80
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About CET Central Securities Corporation
Central Securities Corp is a non-diversified closed-end management investment company. Its investment objective is long-term growth of capital. The company invests in common stocks, bonds, convertible bonds, preferred stocks, convertible preferred stocks, warrants, options real estate, or short-term obligations of governments, banks, and corporations.